Eltrombopag, known by the brand name Revolade, is an oral thrombopoietin receptor agonist used to increase platelet counts in chronic immune thrombocytopenia and certain other low-platelet conditions. In the B2B channel it appears in several presentations, including 25 mg capsules supplied as 14 capsules per pack. For procurement professionals, the priority is confirming that the exact strength and dosage form match the prescribed protocol while maintaining an unbroken chain of quality documentation.
Sourcing eltrombopag begins with verifying the authorization status of the specific presentation in the destination market. Buyers should request a Certificate of Analysis for the lot, the manufacturer's GMP certificate, and batch release documentation, then reconcile these against the import license held by the receiving pharmacy or institution. Because eltrombopag is a prescription hematology agent, legitimate suppliers will require evidence of a licensed importer before issuing a quotation.
Price comparisons must be made on a like-for-like basis: strength, dosage form, pack count, and country of origin all influence both cost and regulatory acceptance. Confusing a capsule presentation with a tablet presentation of the same strength is a frequent cause of customs rejection and clinical substitution errors.
Eltrombopag capsules should be held under the storage conditions stated on the label, protected from excess moisture and extreme heat, and rotated so that the earliest expiry lots are dispensed first. As an oral solid dose, the product does not require refrigerated transit, but temperature-logged shipping is still advisable for long routes or hot climates to preserve stability data.
Inventory planning should reflect that eltrombopag is typically used on a continuing basis rather than as a single course, so steady reorder cadence outperforms sporadic bulk purchasing. Keeping two qualified suppliers for the identical 25 mg capsule pack adds resilience against allocation without creating ambiguity about which product is being stocked.
Q: What presentation of eltrombopag is described here? A: This article focuses on the 25 mg capsule presentation supplied 14 capsules per pack, one of several strengths used in thrombocytopenia management.
Q: Which documents prove eltrombopag quality at import? A: A Certificate of Analysis, batch release papers, and the manufacturer GMP certificate, cross-checked against the importer's license, are the core quality documents.
Q: Do eltrombopag capsules need refrigerated shipping? A: Typically no; controlled room-temperature transport with moisture protection is sufficient, though temperature logging is recommended on long or hot routes.
Q: Why plan eltrombopag as a recurring order rather than bulk stock? A: It is generally used continuously, so predictable reorders reduce waste from expiry and free working capital compared with large speculative purchases.
Eltrombopag, known by the brand name Revolade, is an oral thrombopoietin receptor agonist used to increase platelet counts in chronic immune thrombocytopenia and certain other low-platelet conditions. In the B2B channel it appears in several presentations, including 25 mg capsules supplied as 14 capsules per pack. For procurement professionals, the priority is confirming that the exact strength and dosage form match the prescribed protocol while maintaining an unbroken chain of quality documentation.
Sourcing eltrombopag begins with verifying the authorization status of the specific presentation in the destination market. Buyers should request a Certificate of Analysis for the lot, the manufacturer's GMP certificate, and batch release documentation, then reconcile these against the import license held by the receiving pharmacy or institution. Because eltrombopag is a prescription hematology agent, legitimate suppliers will require evidence of a licensed importer before issuing a quotation.
Price comparisons must be made on a like-for-like basis: strength, dosage form, pack count, and country of origin all influence both cost and regulatory acceptance. Confusing a capsule presentation with a tablet presentation of the same strength is a frequent cause of customs rejection and clinical substitution errors.
Eltrombopag capsules should be held under the storage conditions stated on the label, protected from excess moisture and extreme heat, and rotated so that the earliest expiry lots are dispensed first. As an oral solid dose, the product does not require refrigerated transit, but temperature-logged shipping is still advisable for long routes or hot climates to preserve stability data.
Inventory planning should reflect that eltrombopag is typically used on a continuing basis rather than as a single course, so steady reorder cadence outperforms sporadic bulk purchasing. Keeping two qualified suppliers for the identical 25 mg capsule pack adds resilience against allocation without creating ambiguity about which product is being stocked.
Q: What presentation of eltrombopag is described here? A: This article focuses on the 25 mg capsule presentation supplied 14 capsules per pack, one of several strengths used in thrombocytopenia management.
Q: Which documents prove eltrombopag quality at import? A: A Certificate of Analysis, batch release papers, and the manufacturer GMP certificate, cross-checked against the importer's license, are the core quality documents.
Q: Do eltrombopag capsules need refrigerated shipping? A: Typically no; controlled room-temperature transport with moisture protection is sufficient, though temperature logging is recommended on long or hot routes.
Q: Why plan eltrombopag as a recurring order rather than bulk stock? A: It is generally used continuously, so predictable reorders reduce waste from expiry and free working capital compared with large speculative purchases.
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
العربية
हिन्दी
Türkçe
indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
